To investigate the effects of bornyl caffeate discovered in several species of plant on human breast cancer cells in vitro and the underlying mechanisms.
Human breast cancer cell line MCF-7 and other tumor cell lines (T47D, HepG2, HeLa, and PC12) were tested. Cell viability was determined using MTT assay, and apoptosis was defined by monitoring the morphology of the nuclei and staining with Annexin V-FITC. Mitochondrial membrane potential (MMP) was measured using JC-1 under fluorescence microscopy. Intracellular reactive oxygen species (ROS) were assessed by flow cytometry. The expression of apoptosis-associated proteins was determined by Western blotting analysis.
Bornyl caffeate (10, 25, and 50 μmol/L) suppressed the viability of MCF-7 cells in dose- and time-dependent manners, but neither caffeic acid nor borneol showed cytotoxicity at a concentration of 50 μmol/L. Bornyl caffeate also exerted cytotoxicity to HepG2, Hela, T47D, and PC12 cells. Bornyl caffeate dose-dependently induced apoptosis of MCF-7 cells, increased the expression of Bax and decreased the expression of Bcl-xl, resulting in the disruption of MMP and subsequent activation of caspase-3. Moreover, bornyl caffeate triggered the formation of ROS and activated p38 and c-Jun JNK. In MCF-7 cells, the cytotoxicity of bornyl caffeate was significantly attenuated by SB203580 (p38 inhibitor), SP600125 (JNK inhibitor), z-VAD (pan-caspase inhibitor) or the thiol antioxidant L-NAC.
Bornyl caffeate exerts non-selective cytotoxicity against cancer cells of different origin in vitro. The compound induces apoptosis in human breast cancer MCF-7 cells via the ROS- and JNK-mediated pathways.
Alteration of the physiological apoptotic pathways and disruption of normal homeostasis are known to cause the initiation, progression and metastasis of different cancers1,2. Pharmacological induction of apoptosis in cancer cells has emerged as a key anticancer strategy over the past several decades3,4. Drug-induced apoptosis is readily characterized by microvilli, cell shrinkage, chromatin condensation, nuclear collapse and cellular fragmentation into apoptotic-bodies. The anticancer activity of current anticancer drugs is mediated by multiple apoptotic mechanisms, for example, the activation of mitogen-activated protein (MAP) kinases and caspases. The MAP kinases ERK, p38, and JNK are involved in the regulation of cell proliferation, differentiation and cell death5,6. ERK isoenzymes are mainly regulated by the ras/raf/MEK pathway but are also activated by MEK-1-dependent signals7,8,9. Activation of ERKs promotes the proliferation and survival of most cell types7,10 and regulates cell differentiation and apoptosis11,12. In contrast, the MAP kinases JNK and p38 are often activated by oxidative stress and xenobiotics, and they subsequently induce apoptosis and promote the production of pro-inflammatory cytokines7,13. Interestingly, JNK and p38 exist in multiple isoforms and function in a cell-type-specific manner14. Moreover, their individual isoenzymes may reside in different intracellular compartments and regulate different biological events15,16. Under certain circumstances, p38 and JNK could exert opposing functions and even attenuate cellular apoptotic signals17. Nevertheless, recent studies suggest that p38 and/or JNK directly activate the caspase cascade, thereby mediating the activation of the apoptotic transcription factor c-jun18,19. Activation of the caspase cascade actually hallmarks cell apoptosis20, and notably, many anticancer drugs kill tumor cells by mainly activating caspases, especially caspase-33,21,22.
Bornyl caffeate was initially isolated as an anti-inflammatory and antibacterial compound from several plants, such as Piper caninum (Piperaceae), Piper philippinum, Coreopsis mutica var mutica and Verbesina turbacenina Kunth23,24,25,26. Recent studies have further demonstrated that bornyl caffeate inhibits human neutrophil elastase, HIV-1 integrase and trypanosome cysteine protease26,27,28. The chemical structure of bornyl caffeate represents a combination of two naturally occurring, anti-inflammatory compounds, namely, borneol and caffeic acid. Borneol is widely used to treat against microorganisms, inflammation and pain in Traditional Chinese medicine and other folk medicines29,30. However, borneol could be cytotoxic and genotoxic, depending on its concentration30,31. At non-toxic concentrations, borneol attenuates the cytotoxicity and genotoxicity of hydrogen peroxide (H2O2), whereas borneol at higher concentrations manifests synergy with H2O2, primarily by potentiating the DNA-damaging effects of H2O2. Interestingly, borneol and its derivative MT103 inhibited 7, 12-dimethylbenz(a)anthracene-induced carcinogenesis and tumor growth, while both compounds barely showed toxicity in normal cells32,33. It is believed that borneol kills cancer cells largely by inducing apoptosis. However, caffeic acid and its derivatives are known for their antioxidant, anti-inflammatory and antiviral activities2,34,35,36,37,38. For example, caffeic acid phenethyl ester (CAPE) from insect propolis specifically induces apoptosis in tumor or virally transformed cells but not in parental, normal cells39,40. Octylcaffeate, another example, was recently synthesized and evaluated for its antioxidant, anti-inflammatory and anticancer activities35,41,42. Octylcaffeate also induces apoptosis in human cancer cells and prevents experimental lung metastasis of murine colon 26-L5 carcinoma cells43,44.
The present study was designed to explore the anticancer potential of bornyl caffeate. We recently synthesized bornyl caffeate via direct esterification of caffeic acid with borneol and found that bornyl caffeate strongly induced cell death in human breast cancer MCF-7 cells. The research focus of the present study was to understand the molecular mechanism underlying the cytotoxicity of bornyl caffeate in breast cancer MCF-7 cells.
Materials and methods
Chemicals and antibodies
The antibodies against phospho-Akt, phospho-ERK, phospho-p38, phospho-JNK, Akt, ERK, p38, and JNK were purchased from Cell Signaling Technology (Boston, MA, USA). The antibodies against Bax, Bcl-2, Bcl-xL, caspase-3, PARP were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibody against GAPDH and the goat anti-rabbit IgG horseradish peroxidase (HRP) conjugate antibody were purchased from Sigma-Aldrich Co (St Louis, MO, USA). Other chemicals were obtained from Sigma-Aldrich Co (St Louis, MO, USA) unless indicated otherwise.
Bornyl caffeate was synthesized from caffeic acid by exhaustive esterification with borneol following a modified procedure that was described previously45. At the end of reaction, bornyl caffeate was purified by silica gel chromatography and characterized by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). In this study, bornyl caffeate was diluted in dimethylsulfoxide (DMSO) to make stock solutions of 1 mmol/L and was filtrated using a sterile filter (Millipore, USA). For cell culture, bornyl caffeate was diluted to the appropriate final concentrations in cell-culture medium. Control cells were treated with the same amount of vehicle. The DMSO concentration in the cell-culture medium was controlled below 0.1% (v/v).
MCF-7 and several other cell lines (T47D, HepG2, HeLa and PC12) were obtained from the American Type Cell Culture Collection (Manassas, VA, USA). MCF-7, T47D, HepG2, and HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, USA) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA). PC12 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%FBS, 5% horse serum (Invitrogen, Carlsbad, CA, USA) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA). All cells were cultured at 37 °C in a humidified, 5% CO2 atmosphere.
Measurement of cell viability
The cell viability was evaluated by a standard colorimetric assay as described previously46. In brief, the cells were seeded at 1×104/100 μL per well in a 96-well plate and treated with 0, 10, 25, and 50 μmol/L of bornyl caffeate for 24 h or 50 μmol/L of bornyl caffeate for 0, 3, 6, 12, and 24 h. At the end of the drug treatment, the cell monolayers were incubated with 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) solution (0.5 mg/mL) in phosphate-buffered saline (PBS) for 4 h. The formation of purple formazan was quantified by measuring the absorbance at 570 nm on a microplate reader(Bio-Rad, Hercules, CA, USA). To characterize the cytotoxicity of bornyl caffeate, MCF-7 cells were pretreated with 20 μmol/L of different protein kinase inhibitors (LY294002, PD98059, SP600125, and SB203580) or 50 μmol/L of z-VAD-fmk for 1 h and then treated with bornyl caffeate at the indicated concentrations for 24 h. The cell viability was determined using the MTT assay as described above.
Measurement of lactate dehydrogenase (LDH) release
Extracellular LDH activity was measured using a colorimetric assay and the Cytotoxicity Cell Death Kit (Sigma, St Louis, MO, USA) according to the manufacturer's instructions. Briefly, MCF-7 cells were seeded in 96-well culture plates at a density of 10 000 cells per well. Bornyl caffeate at various final concentrations (0, 10, 25, and 50 μmol/L) or 50 μmol/L of bornyl caffeate was added for the indicated times, and the supernatants were collected to assay LDH activity. The absorbances of all samples were measured at 490 nm on a microplate reader (Bio-Rad, Hercules, CA, USA).
Morphological changes in MCF-7 cells
Cells were washed twice with PBS and then stained with 5 μmol/L Hoechst 33342 in 1×PBS solution for 10 min at room temperature. The cell morphology was examined using a Zeiss fluorescence microscope (Carl ZeissGöttingen, Germany), and the apoptotic cells were defined by chromatin condensation and fragmentation of nuclei.
Flow cytometric analysis of apoptotic cells
After the treatment with bornyl caffeate, the cells (1×106) were freshly harvested and suspended in a 1:1 (v/v) mixture of PBS and 0.2 mol/L Na2HPO4-0.1 mol/L citric acid (pH 7.5). Following fixation with ice-cold ethanol at 4 °C for 1 h, the cells were resuspended in Annexin V binding buffer and then incubated in a buffer containing 200 ng/mL Annexin V-FITC conjugates at room temperature for 15 min. Subsequently, the cells were stained with PI (300 ng/mL) for 10 min, and the stained cells were analyzed on a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA).
The intracellular ROS level was measured based on the ROS-induced formation of the highly fluorescent product 2′,7′-dichlorofluorescein (DCF) from the non-fluorescent dye 2′,7′-dichlorofluorescin diacetate (DCFH-DA), as previously described47,48. Briefly, MCF-7 cells were seeded in a 6-well plate at a density of 2×105 cells per well and incubated for 24 h at 37 °C. Following treatment with bornyl caffeate (0, 10, 25, or 50 μmol/L), the cells were loaded with 20 μmol/L 2′,7′-dichlorofluorescin diacetate (DCFH-DA) in serum-free DMEM medium for 30 min at 37 °C. After the removal of excessive DCFH-DA, the cells were analyzed on a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA).
Visualization of mitochondrial membrane potential
The mitochondrial membrane potential (MMP) was assessed using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-benzimidazol-carbocyanine iodide (JC-1) (Invitrogen, Carlsbad, CA, USA) as previously described49. The cells were cultured in 24-well plates. After a 24-h treatment with bornyl caffeate, the cells were incubated for 30 min at 37 °C with 1 μg/mL of JC-1 in growth medium. MMP depolarization was visualized by measuring fluorescence at the emission wavelengths of 530 nm and 590 nm after excitement at a wavelength of 485 nm with a Zeiss fluorescence microscope (Carl Zeiss, Göttingen, Germany).
Western blotting analysis
The cellular proteins were extracted and analyzed for protein expression as previously described47,50. Briefly, 30 μg of cellular proteins were resolved by electrophoresis in a 10% SDS-polyacrylamide gel and subsequently transferred to polyvinylidene difluoride (PVDF) membrane. Following a 1-h incubation in fresh TBS buffer containing 0.1% Tween-20 and 5% skimmed milk powder, the blots were probed with specific antibodies including rabbit anti-Akt, anti-ERK, anti-p38, anti-JNK, anti-caspase-3, anti-PARP, anti-Bax, anti-Bcl-2, anti-Bcl-xL, anti-GAPDH, anti-phospho-Akt, anti-phospho-ERK, anti-phospho-p38, anti-phospho-JNK, or anti-cleaved PARP. The bound primary antibodies were detected using a goat anti-rabbit IgG-HRP conjugate. The activity of peroxidase on the blot was visualized by enhanced chemiluminescence (ECL) detection reagents (GE Healthcare, Uppsala, Sweden). To characterize the effects of the antioxidants on the bornyl caffeate-induced activation of MAP kinases, MCF-7 cells were pretreated with 1 mmol/L of different antioxidants, except for vitamin C (100 μmol/L), for 1 h, and this was followed by treatment with bornyl caffeate (50 μmol/L) for 24 h. The intracellular proteins were extracted and analyzed by Western blot analysis using specific antibodies.
The data are presented as the mean±SD for three independent experiments. Statistical analysis was performed using a two-tailed, paired Student's t-test, and a P-value <0.05 was considered to be statistically significant.
Synthesis and cytotoxicity of bornyl caffeate
Bornyl caffeate was recently synthesized by exhaustive esterification of caffeic acid with borneol as described (Figure 1)45. The cytotoxicity of bornyl caffeate was evaluated by the standard colorimetric MTT assay in MCF-7 cells, which served as a cell model of human breast cancer46. Following the exposure to bornyl caffeate at concentrations of 0, 10, 25, and 50 μmol/L for 24 h or at a concentration of 50 μmol/L for 0, 3, 6, 12, and 24 h, cell viability was assayed based on the reduction of MTT by mitochondrial reductase in viable cells. As shown in Figure 2A and 2B, bornyl caffeate reduced the cell viability in a concentration- and time-dependent manner. In similar experiments, caffeic acid and borneol showed no cytotoxicity at a concentration of 50 μmol/L after 24 h (data not shown). Bornyl caffeate was also found to be cytotoxic in other cancer cells such as HepG2, Hela, T47D, and PC12 (Figure S1). The cytotoxicity of bornyl caffeate was also verified by measuring LDH release. As shown in Figure 2C and 2D, the LDH activity in the medium was increased in a concentration- and time-dependent manner. Typically, bornyl caffeate at a concentration of 50 μmol/L significantly induced the release of the LDH enzyme after a 6-h incubation. These results suggest that bornyl caffeate may be a potential cytotoxic reagent for cancer cells.
Bornyl caffeate induced apoptosis in human breast cancer MCF-7 cells
To characterize the cytotoxicity of bornyl caffeate, we treated MCF-7 cells with the compound at concentrations of 0, 10, 25, and 50 μmol/L for 24 h. We first examined the nuclear morphology of MCF-7 cells by staining with Hoechst 33342. Upon exposure to bornyl caffeate, the incorporation of fluorescent dye was increased in a concentration-dependent manner (Figure 3A), and it was clear that bornyl caffeate induced the formation of condensed and fragmented cell nuclei (see arrows). Secondly, we detected the appearance of the early apoptosis biomarker phospho-serine at the cell surface by Annexin V-FITC staining. As shown in Figure 3B, bornyl caffeate increased the number of Annexin V-FITC-positive cells in a concentration-dependent manner. Due to the loss of cell-membrane integrity, the incorporation of the fluorescent dye PI was similarly increased. Thirdly, we investigated the effect of bornyl caffeate on the mitochondrial membrane potential (MMP) using a cationic fluorescent probe JC-1. JC-1 is preferably incorporated into the mitochondrion of viable cells, giving rise to a maximal fluorescence emission at ∼590 nm (red), whereas the maximal fluorescence emission of JC-1 in the cytosol appears at ∼525 nm (green). By measuring such a shift in the fluorescence emission by fluorescence microscopy, mitochondrial polarization was readily detected in bornyl caffeate-treated cells (Figure 3C). Notably, in the cells exposed to 50 μmol/L of bornyl caffeate, a significant amount of the fluorescent dye JC-1 was present in the cytosol rather than the mitochondria (see arrows).
Bornyl caffeate stimulates ROS formation
To clarify the effect of bornyl caffeate on the intracellular redox status, we determined the intracellular ROS level by measuring the oxidation of non-fluorescent DCFH-DA to its highly fluorescent derivative 2′,7′-dichlorofluorescein (DCF). As shown in Figure 3D, bornyl caffeate stimulated ROS formation in a concentration-dependent manner.
Effect of bornyl caffeate on apoptosis biomarkers
To verify the induction of apoptosis by bornyl caffeate, we investigated the effect of bornyl caffeate on the expression of the pro-apoptotic protein Bax and anti-apoptotic proteins Bcl-2 and Bcl-xL. We found that bornyl caffeate up-regulated the intracellular level of Bax but down-regulated the intracellular level of Bcl-xL in a concentration-dependent manner (Figure 4A and 4B). The expression of Bcl-2 was not dramatically affected even when the drug concentration was increased as high as 50 μmol/L. We further clarified if bornyl caffeate could trigger the activation of the caspase cascade by monitoring the cleavage of caspase-3 and its action on PARP. As shown in Figure 4C and 4D, bornyl caffeate at concentrations of 10, 25, and 50 μmol/L triggered the cleavage of caspase-3. Importantly, upon activation, caspase-3 subsequently degraded PARP, giving rise to a reduction in the intracellular PARP level in a concentration-dependent manner.
Bornyl caffeate persistently activates the MAP kinases JNK and p38
To explore the mechanisms modulating the induction of apoptosis, we investigated the effect of bornyl caffeate on different protein kinases. MCF-7 cells were treated with bornyl caffeate (50 μmol/L) for various periods (0, 0.5, 1, 3, 6, and 12 h). At the end of treatment, the cellular proteins were resolved by 10% SDS-PAGE and analyzed by Western blotting. As shown in Figure 5A and 5B, two pro-survival kinases, Akt and ERK, were marginally activated at the early stage (0.5–3 h); however, the phospho-Akt and phospho-ERK signals were gradually reduced to basal levels. In contrast, the phospho-p38 and phospho-JNK signals were gradually increased over a period of 12 h. These results stimulated us to further examine if activation of the MAP kinases p38 and JNK was dependent on the concentration of bornyl caffeate. We found that bornyl caffeate at a concentration of 50 μmol/L induced a dramatic increase in the phospho-p38 and phospho-JNK signals, whereas, at concentrations of 10 and 25 μmol/L, the phospho-p38 and phospho-JNK signals were barely detectable (data not shown).
Antioxidants differentially attenuate the activation of the MAP kinases p38 and JNK
To understand how bornyl caffeate activated the MAP kinases p38 and JNK, we focused on the potential role of intracellular ROS. We employed four common antioxidants, NAC, GSH, vitamin C, and Trolox, to scavenge intracellular ROS. By detecting phospho-p38 and phospho-JNK in cells that were treated with bornyl caffeate and antioxidants, alone or in combination, we found that antioxidants differentially affected the activation of p38 and JNK by bornyl caffeate. In particular, antioxidants effectively antagonized the effect of bornyl caffeate on the activation of p38 but showed little activity against the activation of JNK (Figure 5C).
Characterization of the cytotoxicity of bornyl caffeate
To explore the mechanisms by which bornyl caffeate induced apoptosis, we first investigated the effect of protein kinase inhibitors on the cytotoxicity of bornyl caffeate. As shown in Figure 6A, the p38 inhibitor SB203580 and JNK inhibitor SP600125 significantly attenuated the cytotoxicity of bornyl caffeate, whereas neither the ERK inhibitor PD98059 nor the PI3K/Akt inhibitor LY294002 showed any effect. These results suggest that activation of the MAP kinases p38 and JNK plays a role in the cytotoxicity of bornyl caffeate. Second, we investigated the effect of different antioxidants on the cytotoxicity of bornyl caffeate. To our surprise, all of these antioxidants, except for the thiol antioxidant L-NAC, failed to protect the cells against the cytotoxicity of bornyl caffeate (Figure 6). Third, we investigated the effect of the pan-caspase inhibitor z-VAD on the cytotoxicity of bornyl caffeate. As shown in Figure 6C, inhibition of caspases by z-VAD resulted in partial protection of the cells against the cytotoxicity of bornyl caffeate. Taken together, the cytotoxicity of bornyl caffeate can be partially attenuated by scavenging ROS and inhibiting MAP kinases and the caspase cascade.
In the present study, we investigated the anticancer mechanisms of bornyl caffeate in the human breast cancer cell line MCF-7. By assaying the effect of bornyl caffeate on the reduction of MTT in viable cells and the release of lactate dehydrogenase (LDH) from dead cells, we found that bornyl caffeate exhibited strong cytotoxicity in breast cancer MCF-7 cells in a dose- and time-dependent manner (Figure 2). To explore the underlying mechanisms for this process, we further characterized the cytotoxicity of bornyl caffeate by examining the morphological changes of cell nuclei and the presentation of the early apoptotic marker phosphoserine at the cell surface. As shown in Figure 3A and 3B, bornyl caffeate increased the shrinkage of cell nuclei and staining of Annexin V-FITC in a concentration-dependent manner, suggesting an apoptotic mechanism. These apoptotic features were supported by an increase in the protein level of pro-apoptotic Bax and a decrease in the intracellular level of anti-apoptotic Bcl-xl (Figure 4A). In line with the increase in the expression of the mitochondria-damaging protein Bax, bornyl caffeate actually disrupted the integrity of the mitochondrial membrane and induced the activation of caspase-3 (Figure 3C and 4C). These results stimulate us to postulate that the cytotoxicity of bornyl caffeate is mediated by inducing apoptosis in cancer cells.
Induction of apoptosis is a major anticancer mechanism for a variety of cancer therapies3. Caffeate derivatives such as CAPE and octylcaffeate have been previously demonstrated to induce apoptosis in various cancer cell lines and animal models43,51. The common caffeate group in these compounds is presumably the key structural element responsible for inducing apoptosis. Bornyl caffeate is a combination of two well-known, anti-inflammatory chemical elements, caffeate and borneol, which renders this compound a potential anticancer drug candidate. Our results provided experimental evidence that support the potential of bornyl caffeate in inducing apoptosis in the breast cancer cell line MCF-7. We also observed similar cytotoxicity in several other cancer cell lines such as hepatoma HepG2, cervical cancer HeLa and pheochromocytoma PC12 cells (Figure S1). Drug-induced apoptosis of cancer cells is ultimately executed by the caspase cascade, especially through caspase 3/6/752,53. However, various anticancer drugs, irradiation and Fas ligand may induce apoptosis through different mechanisms4,54.
Aberrant formation of ROS is well recognized as a carcinogenic factor driving the malignant transformation of normal cells via inducing oxidative DNA damage55,56. However, the induction of ROS formation plays an important role in the chemotherapeutic activity of several anticancer drugs and a large number of anticancer compounds57,58. Drug-induced ROS mediates the activation of MAP kinases, disrupts MMP and ultimately activates apoptotic caspases in cancer cells59,60,61. Following treatment with bornyl caffeate, the intracellular ROS levels were measured using a widely used, permeable probe 2′,7′-dichlorofluorescin diacetate (DCFH-DA)62. After passive loading to the cells, DCFH-DA is hydrolyzed into 2′,7′-dichlorodihydrofluorescin (DCFH) by intracellular esterase. DCFH is subsequently oxidized by ROS to become the highly fluorescent compound 2′,7′-dichlorofluorescein (DCF). As shown in Figure 3D, bornyl caffeate stimulated ROS formation in a concentration-dependent manner. To determine the effect of bornyl caffeate on the integrity of the mitochondrial membrane, we selected a cationic dye, JC-1, to indicate mitochondrial polarization. Previous studies suggest that JC-1 forms red-fluorescent J-aggregates more specifically in the mitochondria and offers better consistency in its response to drug-induced depolarization than other cationic dyes such as DiOC6(3) and rhodamine 12363. We separately visualized the green and red emission components by using optical filters designed for fluorescein and tetramethylrhodamine. As a result, we observed that bornyl caffeate caused mitochondrial depolarization in a concentration-dependent manner (Figure 3C). Moreover, bornyl caffeate profoundly upregulated the Bax level and downregulated the Bcl-xL level, thereby causing a dramatic shift in the Bax/Bcl-xL ratio to allow mitochondrial apoptosis to occur64. As shown in Figure 4C, apoptosis-executing molecules such as caspase-3 and its substrate poly (ADP-ribose) polymerase (PARP) were sequentially activated. Interestingly, pre-treatment with the pan-caspase inhibitor z-VAD-fmk only partially inhibited bornyl caffeate-induced apoptosis, suggesting the involvement of caspase-dependent and -independent mechanisms65,66.
ROS regulates cell proliferation, differentiation and apoptosis via the activation of protein kinase C (PKC), ERK, the p38 MAP kinase and JNK19,67,68. In cells exposed to 50-μmol/L bornyl caffeate, we detected a gradual increase in phospho-p38 and phospho-JNK MAP kinases over a period of 12 h, whereas phospho-Akt and phospho-ERK1/2 were only detectable during the first 3 h (Figure 5A). To determine the mechanism by which bornyl caffeate acts on the p38 MAP kinase and JNK, we applied different antioxidants to scavenger the ROS that were induced by bornyl caffeate. The antioxidants NAC, GSH, Trolox, and vitamin C attenuated the activation of the p38 MAP kinase by bornyl caffeate but showed little effect on the activation of JNK (Figure 5C). These results suggest that bornyl caffeate could induce the activation of the MAP kinases p38 and JNK via ROS-dependent and -independent pathways. Not surprisingly, JNK can be activated by multiple stimuli such as cytokines (eg, tumor necrosis factor and interleukin-1), reactive oxygen species (ROS), pathogens, toxins, drugs, endoplasmic reticulum stress, free fatty acids and metabolic changes69. For example, garlic-derived, organosulfur compounds such as diallyl polysulfides activate JNK via direct chemical modification of the cytoskeletal protein tubulin and depends less on intracellular ROS70. Another study demonstrated that the proinflammatory mediator high-mobility group box-1 protein (HMGB1) induced MUC8 expression in a JNK and PI3K/Akt signaling pathway-dependent manner that was ROS-independent71. Further investigation is needed to clarify how bornyl caffeate activates JNK in a ROS-independent manner. To explore the mechanisms underlying the cytotoxicity of bornyl caffeate, we employed antioxidants, the JNK inhibitor SP600125, the p38 MAP kinase inhibitor SB203850, the PI3K/Akt inhibitor LY294002 and the pan-caspase inhibitor z-VAD-fmk. As shown in Figure 6, the cytotoxicity of bornyl caffeate was partially attenuated by the JNK inhibitor SP600125, p38 MAP kinase inhibitor SB203850 and antioxidants NAC and pan-caspase z-VAD-fmk. However, none of these reagents could completely rescue the cells from bornyl caffeate-induced injury. These results suggest that the cytotoxicity of bornyl caffeate is mediated by multiple mechanisms.
In conclusion, the present study demonstrated that bornyl caffeate induced cell death in breast cancer MCF-7 cells by inducing apoptosis. We found that bornyl caffeate stimulated the formation of ROS and activated the stress-responsive MAP kinases JNK and p38 in MCF-7 cells. Our results suggest that ROS-dependent pathways and the ROS-independent JNK pathway contribute to the cytotoxicity of bornyl caffeate. Thus, bornyl caffeate may serve as a potential lead for the development of new anticancer drugs.
This work was supported by the Seed Funding Programme for Basic Research, University of Hong Kong (Project 201111159212, to JR) and the National Natural Science Foundation of China, Specialized Research Fund for the Doctoral Program of Higher Education on 2011 (project 20106101110001, to XZ).
Cytotoxicity of bornylcaffeate indifferentcell line.
About this article
Supplementary figure is available at the Acta Pharmacologica Sinica website.